Background: In approximately half of cases of primary aldosteronism (PA), the cause is a surgically-resectable unilateral aldosterone-producing adrenal adenoma. However, long-term data on surgical outcomes are sparse. Aim: We report on clinical outcomes post-adrenalectomy in a cohort of patients with PA who underwent surgery. Design: Retrospective review of patients treated for PA in a single UK tertiary centre. Methods: Of 120 consecutive patients investigated for PA, 52 (30 male, median age 54, range 30-74) underwent unilateral complete adrenalectomy. Blood pressure, number of antihypertensive medications, and serum potassium were recorded before adrenalectomy, and after a median follow-up period of 50 months (range 7-115). Recumbent renin and aldosterone were measured, in the absence of interfering antihypertensive medication, !3months after surgery, to determine if PA had been biochemically cured. Results: Overall, blood pressure improved from a median (range) 160/95 mmHg (120/80-250/150) pre-operatively to 130/80 mmHg (110/70-160/93), P < 0.0001. 24/52 patients (46.2%) had cured hypertension, with a normal blood pressure postoperatively on no medication. 26/52 (50%) had improved hypertension. 2/52 patients (3.8%) showed no improvement in blood pressure post-operatively. Median (range) serum potassium level increased from 3.2 (2.3-4.7) mmol/l pre-operatively to 4.4 mmol/l (3.3-5.3) post-operatively, P < 0.0001). Median (range) number of antihypertensive medications used fell from 3 (0-6) pre-to 1 post-operatively (range 0-4), P < 0.0001. Conclusions: Unilateral adrenalectomy provides excellent long-term improvements in blood pressure control, polypharmacy and hypokalaemia in patients with lateralizing PA. These data may help inform discussions with patients contemplating surgery.
Introduction
Primary aldosteronism (PA) is an important cause of hypertension that, if left untreated, results in significant cardiometabolic risk over and above that conferred by elevated blood pressure alone. 1, 2 Prevalence estimates of PA range between 5 and 14% of unselected hypertensive patients, with higher figures (20-25%) in those with 'treatment resistant' hypertension. [3] [4] [5] [6] [7] In approximately half of cases, the cause is a surgically resectable unilateral aldosterone-producing adrenal adenoma, making PA the most common potentially curable form of hypertension. 3, 7, 8 Despite this, the number of adrenalectomies in the UK for PA falls far short of that which would be predicted using even the most conservative prevalence estimates. With the availability of high-throughput renin assays, the detection of PA in primary care and specialist hypertension clinics has improved markedly, 9 but physicians are still seemingly reluctant to complete the assessment by looking for a curable cause. One obvious reason is lack of access to lateralization tests. Adrenal venous sampling (AVS, the current 'gold standard' investigation to distinguish unilateral from bilateral disease) is a complex, invasive test available to a satisfactory standard in only a few centres. 10 A further reason is that long-term outcome data from unilateral adrenalectomy for PA are sparse and, together with a lack of a 'prediction' test to indicate who will benefit most from surgery, this makes surgical recommendations for individual patients difficult.
We have previously reported on the use of a designated radiological grading system to predict lateralization in PA; 11 and
we have also compared its performance to a recently-published clinical prediction score 12 developed to try and reduce the numbers of patients requiring access to AVS. 13 Like most other units, in those reports we used short-term endpoints (results of AVS, restoration of normal renin/aldosterone physiology and blood pressure changes at 3 months post-adrenalectomy), but patients and their physicians are more concerned with longerterm outcomes after surgical treatment. Here, we report on blood pressure outcomes after a median of 50 months postadrenalectomy in those patients from our cohort who underwent surgery.
Materials and methods

Patients
The details of our unit's investigational protocol have been previously described. 11, 13 The diagnosis of PA was based on a history of poorly controlled hypertension together with a suppressed plasma renin activity (PRA) of <0.2 pmol/ml/h and an elevated serum aldosterone after salt loading (120 mmol/day for 3 days) 14 Metabolic assessments were performed following cessation of all interfering antihypertensive medication for an appropriate period of time (6 weeks for spironolactone; 2 weeks for other diuretics, beta-adrenergic antagonists, angiotensinconverting enzyme inhibitors and angiotensin II receptor blockers) and all samples were drawn in the morning with patients supine after a period of 30 min recumbent rest. Generous oral potassium supplementation (48-72 mmol potassium daily) was given as necessary. Of 120 consecutive patients, 52 underwent laparoscopic or laparoscopic-assisted complete adrenalectomy by one of two surgeons (RC or LP) at least 6 months before follow-up data for this study were gathered. All surgeries took place between January 2005 and August 2014. Patients underwent measurement of recumbent renin and aldosterone at least 3 months post adrenalectomy to determine if PA had been cured by surgery. Clinical outcomes recorded at the most recent review prior to surgery and during follow-up included measurement of resting, supine blood pressure (in the outpatient setting) and/or measurement of home blood pressures using devices that patients purchased themselves; the number of antihypertensive medications being taken in those patients whose blood pressure remained elevated postoperatively; and serum potassium. The date of each patient's most recent concurrent clinical review, blood pressure and serum potassium measurement was taken as the date from which the duration of follow-up after surgery was calculated for this study. This project received institutional board review.
Assays
Serum aldosterone was measured by 125 I competitive radioimmunoassay (Coat-A-Count; Siemens Medical Solutions Diagnostics, Frimley, UK). Renin activity was assayed in EDTA plasma, using generation of angiotensin I from endogenous substrate angiotensinogen, during a 90 min incubation at 37 C, in the presence of angiotensin converting enzyme inhibitors. Angiotensin I generated was measured by RENCTK
125
I competitive radioimmunoassay kit (Diasorin, Saluggia, Italy) with blank subtraction of angiotensin I levels in aliquots incubated at 4 C.
Serum potassium was analysed by indirect ion selective electrode.
Adrenal imaging
All patients underwent a triphasic CT scan of the upper abdomen, using 2.5-mm space intervals reformatted to 1.25 mm as previously described. 11 Images were acquired pre-contrast, and at 30 and 90 s post-contrast. All the scans were analysed by a single radiologist (AS), measuring the thickness of the body of the gland and of each limb using the method described by Vincent et al.
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Adrenal vein sampling
All AVS procedures were performed by a single operator (MM) during a continuous Cosyntropin infusion, with samples obtained from both adrenal veins and the infrarenal inferior vena cava. In accordance with other units, 16 we defined successful cannulation as an adrenal/peripheral vein cortisol ratio ! 5:1 during ACTH stimulation; and unilateral aldosterone excess was diagnosed if the cortisol-corrected aldosterone gradient (A/C ratio) was ! 4:1. A ratio < 3 was indicative of bilateral aldosterone hypersecretion and one of between 3 and 4 was considered equivocal. 17 
Histopathology
All adrenalectomy specimens were reported by a single pathologist (DB) according to WHO criteria. 18 
Clinical definitions
In line with previous reports, [19] [20] [21] we distinguished between biochemical cure of PA (defined as restoration of normal recumbent renin and aldosterone levels) and cure of hypertension (blood pressure <140/90 mmHg on no medication). Impro vement, but not cure, of blood pressure was defined as a reduction in the number of antihypertensive drugs required to control blood pressure. Those with no improvement satisfied neither of the above definitions. Patients requiring the same number of medications, but with one or more drugs being taken at a lower dose postoperatively, were considered not to have derived useful clinical benefit.
Statistical analysis
Continuous data were described using medians and ranges and categorical data with percentages. Wilcoxon rank sum tests were used to compare pre-and post-operative blood pressure and potassium levels. Univariate relative risks were calculated to determine which factors predicted those who were cured post-operatively and multivariate Poisson regression with robust variances and backwards selection was used to calculate multivariate relative risks. Poisson regression was also used to calculate incidence rate ratios to determine factors that were associated with the number of post-operative antihypertensive medications needed. Statistical significance was taken as P < 0.05. All analyses were performed in Stata version 12 (StatCorp, College Station, TX).
Results
Demographics and follow-up
The cohort consisted of 30 males and 22 females, median age 54 (range 30-74). Median duration of follow-up was 50 months (range 7-115). Post-operative renin and aldosterone levels all measured at least 3 months following surgery. The duration of follow-up refers to the length of time since surgery at which clinical status, blood pressure and serum potassium level were most recently evaluated.
Blood pressure, potassium and anti-hypertensive medication Median number of antihypertensive medications used improved from median 3 pre-to median 0.5 post-operatively (P < 0.0001). One patient developed clinically significant, persistent hyperkalaemia post-operatively requiring the long-term use of fludrocortisone. This patient had background, longstanding type II diabetes mellitus and subsequent attempts to withdraw fludrocortisone were associated with redevelopment of hyperkalaemia.
A total of 24/52 patients (46.2%) had cured hypertension, with a normal blood pressure post-operatively on no medication. 26/52 (50%) satisfied the criteria of improved hypertension, from a median of 160/98 mmHg (range 140/80-250/150) to a median of 130/80 mmHg (120/70-169/93, P ¼ 0.0004). The increase in serum potassium level and reduction in number of antihypertensive medications in those with improved but not cured hypertension was also statistically significant (P < 0.0001 for both). Post-operative renin and aldosterone levels were no different in those cured of hypertension from those whose blood pressure was improved but not cured. Patient outcomes in terms of blood pressure, serum potassium levels, and number of antihypertensives required are shown in more detail in Table 1 .
The group who were cured post-operatively contained, proportionately, more females than the group who were improved but not cured (18/24 vs 4/26, P < 0.0001). This significant association was maintained on multivariate analysis, adjusting for patient age, pre-operative blood pressure, number of preoperative antihypertensives and duration of follow-up (relative risk ¼ 2.91, P ¼ 0.002). However, patient age, pre-operative blood pressure, number of pre-operative antihypertensives and duration of follow-up did not predict post-operative cure or improvement.
Multivariate analysis revealed that the number of postoperative antihypertensive medications needed was 76% lower in females (P ¼ 0.03). However, post-operative potassium levels were not influenced by any predictive pre-operative factor, and the level of pre-operative hypertension did not correlate with post-operative blood pressure.
A total of 2/52 patients (3.8%) showed no improvement in blood pressure post-operatively, with only slight changes in blood pressure and no change in the number of medications required, as shown in Table 1 . These patients have been previously described in detail within a previous publication.
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Biochemical resolution of PA Post-operative renin and aldosterone measurements, performed ! 3 months after surgery, were available on 44/52 (84.6%), and were normal in 41/44 (93.2%). Renin remained suppressed post-operatively in three patients. One of these patients showed no improvement in blood pressure post-operatively. The other two showed some clinical improvement but were not cured of their hypertension.
Histopathology findings
A total of 20/24 patients (83.3%) cured post-operatively had fully excised, typical Conn's adenomas on histological examination of the operative sample. The remainder had typical Conn's adenomas with background hyperplasia (n ¼ 2), primary adrenal hyperplasia (n ¼ 1), and one patient whose adrenal gland was reported as histologically within normal limits. Of the patients improved but not cured post-operatively, 23/26 (88.5%) had typical Conn's adenomas on histology, 2/26 (7.7%) had typical adenomas with background hyperplasia, and 1/26 (3.8%) had two separate adenomas within the same gland.
In the two patients who showed no clinical improvement post-operatively, histological examination of the adrenal glands confirmed the presence of a fully excised, adrenocortical adenoma in one case and a fully excised adrenocortical adenoma with a background of mild cortical hyperplasia in the other case. The former case had biochemically cured PA postoperatively; the latter had persistently suppressed renin and high aldosterone levels.
Discussion
In this study, we report clearly-defined clinical outcomes in a cohort of patients undergoing unilateral adrenalectomy as treatment for PA. Almost all patients (94%) derived clinical benefit, with significant improvements in blood pressure control, normalization of serum potassium, plasma renin and plasma aldosterone levels and a reduction in or elimination of antihypertensive therapy. To our knowledge, this is the largest reported UK series to date, with a longer duration of follow-up than previous reports. 22, 23 Furthermore, each of our patients underwent an identical detailed and previously published investigational protocol. 11, 13 There are a number of reports in both the endocrine and surgical literature that describe clinical outcomes in patients undergoing adrenalectomy as treatment for unilateral PA. Although important contributions at the time, some of these series have limited relevance to contemporary practice in that patient selection for surgery involved various combinations of early CT technology (before the advent of multi-slice scanners), 5, 24 postural stimulation studies 20, 24 and iodo-cholesterol imaging. 24 Other than historical interest the latter two no longer have any role in the subtyping of PA. In other series, a focus on peri-operative morbidity and surgical detail is at the expense of information on lateralization tests and patient selection for surgery, 21, 25, 26 raising questions about the applicability of reported outcomes to the protocols and practices of other units. In this report, we have attempted to combine details of the investigational work-up (using AVS and a previously reported radiological grading score 11 ); the criteria for determining lateralization and surgical referral; and robustly defined clinical outcomes from a consecutive series of patients undergoing adrenalectomy as treatment for unilateral PA. Our overall purpose was to provide outcome data relevant to a contemporary investigational protocol to guide clinicians and patients contemplating a surgical strategy for the treatment of this condition. Given the published prevalence of PA and the fact that such a small proportion of patients undergo adrenalectomy, 17 any attempt to increase the number of patients undergoing lateralization tests and subsequent surgical treatment (if indicated) should be accompanied by sound data as to the expected outcome. 27 Although we report on fewer cases than other series, 22, 23 potential strengths of our study include the features that all patients followed an identical investigational protocol, with no change in imaging technology or AVS criteria over the study time period; and that we have clinical follow-up data on all patients who underwent surgery since our prospectively gathered PA dataset was established. The authors of a recent report acknowledge the issue of approximately half of their cohort being excluded from analysis due to missing data, 19 although the proportions of patients achieving cure of hypertension and cure of PA but with ongoing requirements for blood pressure-lowering medication are strikingly similar at 41.7 and 46.5%, respectively, compared with 46.2 and 50% in our cohort. In a separate series (also with approximately half of patients excluded from analysis due to missing follow-up data), 28 the cure rate was 15.3%, although almost all non-cured patients experienced clinical improvement (lower blood pressure on fewer medications).
Although not specifically addressed in their analysis or discussion, there was a strikingly unequal distribution of black African patients between the cured and non-cured patients in that study. Unlike our cohort, the association of hypertension duration with lack of cure was statistically significant. Black Africans are known to have a high prevalence of essential hypertension and be particularly prone to end-organ damage from elevated blood pressure, so it may be that the apparently lower cure rate, at least in part, can be explained by the ethnic mix of the respective cohorts. The vast majority of our patients were white Caucasian. Predicting surgical outcomes for individual patients remains difficult. Previous reports have suggested that increasing age and diameter of adrenal adenoma are associated with a less favourable blood pressure response to surgery 23 ; with better outcomes being predicted by normal body mass index, shorter duration of hypertension and female gender. Our data on outcome in women concord with this. We did not examine the effect of hypertension duration on outcome as we were not confident in the accuracy of the documentation of hypertension onset in many patients. However, the observation of a correlation between the number of pre-and post-operative antihypertensive medications required to achieve blood pressure control would be in keeping with the concept that, in PA, longstanding, severe pre-operative hypertension is unlikely to be completely cured.
This study again highlights the importance of cumulative expertise in AVS. In a previous report from our group of 50 patients, 11 the bilateral cannulation rate was 52%, increasing to 78% in a later report of 75 patients 13 and now stands at 92% (internal audit data). The multicentre AVS International Study examining 2604 cases reported a low rate (0Á61%) of adrenal vein rupture, which was inversely related to the number of procedures performed by each radiologist. 29 No significant complications, other than minor haematoma formation at the femoral vein puncture site, were observed in our patients, emphasizing the value of investigating PA patients in specialist centres. Our study has obvious limitations. First, although our data are prospectively gathered, our analysis is retrospective with its associated in-built flaws. Second, although the use of a continuous cosyntropin infusion greatly assists in the ascertainment of accurate adrenal vein cannulation, it is thought by some to reduce the likelihood of correct lateralization of aldosterone excess, due to its effect on increasing aldosterone secretion even in the unaffected gland. 30 Although flexibility of decisionmaking exists within our protocol, the standard approach of the group has been to require a lateralization ratio of ! 4:1 prior to surgical referral together with suppression of the contralateral (non-adenoma containing) adrenal compared to the Inferior Vena Cava (IVC); an approach supported by recently published consensus guidelines on the use of AVS. 10 Recent data (particularly from functional imaging such as 11 C-metomidate PET scanning) indicate that a population of patients exists whose aldosterone excess is unilateral but with a lower degree of lateralization. 31 A prospective study comparing the sensitivity and specificity of AVS and 11 C-metomidate scanning would be informative in this regard. Third, any study conducted within a specialist centre has the potential for referral bias. It is hard to assess the effect of this; it could be that the patients referred to our centre are 'enriched' with those considered likely to have surgically-treatable PA but it could also be that patients with clearly identified adrenal lesions on imaging are treated in secondary care, leading to an increased prevalence of bilateral disease requiring AVS for confirmation in our population. Finally, in line with other reports, our follow-up blood pressure data represent a combination of patient-reported home readings and those recorded during outpatient visits. Such an approach clearly falls short of largescale clinical trials in (e.g.) essential hypertension, but represents the 'real life' of clinical practice and outcomes-based reporting in this field.
In summary, we present clinical outcomes in a large cohort of surgically treated patients with PA. The data complement previous reports of the accuracy of a combination of AVS and a radiological grading system for clinical decision-making in this condition. The findings that nearly half of patients have their hypertension cured and that almost all patients derive useful clinical benefit provides important information to discuss with patients contemplating an adrenalectomy as treatment for PA.
